Strong science is critical to FDA’s ongoing review of the products it regulates. FDA is investing in an FDA-wide nanotechnology regulatory science program to further enhance FDA’s scientific capabilities, including developing necessary data and tools to identify properties of nanomaterials and assess the impact they may have on products. In general, FDA considers the current framework for safety assessments sufficiently robust and flexible to be appropriate for a variety of materials, including nanomaterials.
FDA’s Action on Nanotechnology
The draft cosmetics guidance, describes FDA’s current thinking on the safety assessment of nanomaterials when used in cosmetic products.
FDA’s Approach to Regulation of Nanotechnology Products